Literature DB >> 14722392

Can prescription refill feedback to physicians improve patient adherence?

Joel M Schectman1, John B Schorling, Mohan M Nadkarni, John D Voss.   

Abstract

BACKGROUND: Although adherence to long-term drug therapy is an important issue, the means to facilitate its assessment and improvement in clinical practice remain a challenge.
OBJECTIVE: To evaluate the impact of prescription refill feedback and adherence education provided to primary care physicians.
METHODS: We provided 83 resident and attending physicians at a university-based general internal medicine practice with refill adherence reports on each of 340 diabetic patients. An educational session on adherence assessment and improvement techniques was held, and all physicians received a written outline on this topic. Physician attitude toward the intervention and 6-month change in refill adherence (doses filled/doses prescribed) of their patient panels were assessed. A nonrandomized comparison group of patients receiving hypertension medications for whom the physicians did not receive feedback was also evaluated.
RESULTS: The overall improvement in mean refill adherence was not significant (83.9% vs 86.0%, P=0.18). The educational session was attended by 53% of the physicians. The patient refill adherence of physicians attending the educational session improved by 5.0% (P<0.0009) with no significant change among patients of physicians not attending the session. There was no adherence change among patients for whom physicians did not receive refill feedback data, regardless of educational session attendance.
CONCLUSIONS: Patients of physicians that received refill feedback and attended an educational session improved their refill adherence. After replication of these results in a randomized trial, broad implementation of this approach could have substantial impact from a public health perspective, given the ubiquity of prescription claims data.

Entities:  

Mesh:

Year:  2004        PMID: 14722392     DOI: 10.1097/00000441-200401000-00005

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  9 in total

1.  Clinical outcomes and adherence to medications measured by claims data in patients with diabetes.

Authors:  Manel Pladevall; L Keoki Williams; Lisa Ann Potts; George Divine; Hugo Xi; Jennifer Elston Lafata
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

2.  Are two commonly used self-report questionnaires useful for identifying antihypertensive medication nonadherence?

Authors:  Benjamin D Gallagher; Paul Muntner; Nathalie Moise; Jenny J Lin; Ian M Kronish
Journal:  J Hypertens       Date:  2015-05       Impact factor: 4.844

3.  A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma.

Authors:  L Keoki Williams; Edward L Peterson; Karen Wells; Janis Campbell; Mingqun Wang; Vimal K Chowdhry; Matthew Walsh; Robert Enberg; David E Lanfear; Manel Pladevall
Journal:  J Allergy Clin Immunol       Date:  2010-05-31       Impact factor: 10.793

4.  A randomized controlled trial to provide adherence information and motivational interviewing to improve diabetes and lipid control.

Authors:  Manel Pladevall; George Divine; Karen E Wells; Ken Resnicow; L Keoki Williams
Journal:  Diabetes Educ       Date:  2014-12-08       Impact factor: 2.140

5.  Study protocol: the Adherence and Intensification of Medications (AIM) study--a cluster randomized controlled effectiveness study.

Authors:  Michele Heisler; Timothy P Hofer; Mandi L Klamerus; Julie Schmittdiel; Joe Selby; Mary M Hogan; Hayden B Bosworth; Adam Tremblay; Eve A Kerr
Journal:  Trials       Date:  2010-10-12       Impact factor: 2.279

6.  Non-adherence to drug therapy and drug acquisition costs in a national population--a patient-based register study.

Authors:  Bo Hovstadius; Göran Petersson
Journal:  BMC Health Serv Res       Date:  2011-11-28       Impact factor: 2.655

Review 7.  A systematic review of interventions addressing adherence to anti-diabetic medications in patients with type 2 diabetes--impact on adherence.

Authors:  Sujata Sapkota; Jo-anne Brien; Jerry Greenfield; Parisa Aslani
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

Review 8.  A Systematic Review of Interventions Addressing Adherence to Anti-Diabetic Medications in Patients with Type 2 Diabetes--Components of Interventions.

Authors:  Sujata Sapkota; Jo-Anne E Brien; Jerry R Greenfield; Parisa Aslani
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

9.  Sustained hyperglycemia among patients with diabetes: what matters when action is needed?

Authors:  Jennifer E Lafata; Elizabeth A Dobie; George W Divine; Marianne E Ulcickas Yood; Bruce D McCarthy
Journal:  Diabetes Care       Date:  2009-08       Impact factor: 19.112

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.